Previous research has suggested that there is a link between depression and tea drinking. Now, a new study is investigating this relationship further. Depression is common among older adults, with 7% of those over the age of 60 years reporting “major depressive disorder.” Accordingly, research is underway to identify possible causes, which include genetic predisposition,… Read More »
Print this page 21 November 2019 — AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).1 The US approval was granted under the FDA’s Real-Time Oncology Review and newly established Project Orbis programmes. The approval is based on positive… Read More »
FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions Print this page SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the U.S. Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) for the… Read More »
The U.S. Preventive Services Task Force (USPSTF) has issued a new recommendation that all adults ages 18 to 79 should be screened for hepatitis C virus (HCV) at least once, regardless of risk factors. Those under 18 or over 79 should also be screened if they are at risk because, for example, they share syringes… Read More »